2979938
Last Update Posted: 2018-05-07
Recruiting has ended
Males accepted | Under |
25 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
Understanding Excretion and Infectivity of Zika Virus in Semen During and After Infection
In this prospective observational study the investigators will report on 20 male subjects with proven WHO-classification Zika infection. These subjects will be followed up for a maximum of 12 months to observe the presence, viral load and infectivity of Zika virus (ZIKV) in semen over time.
In this prospective observational study the investigators will report on 20 male subjects with proven WHO-classification Zika infection. These subjects will be followed up for a maximum of 12 months to observe the presence, viral load and infectivity of Zika virus (ZIKV) in semen over time.
Knowledge of the possible presence, infectivity and persistence of ZIKV in semen will provide evidence-based data for
- estimating of the risk of sexual transmission of ZIKV in the general population
- antenatal guidelines for the prevention of sexual transmission of ZIKV to the fetus
- advising couples on the length of time that pregnancy should be avoided in women wishing to conceive after their partner's ZIKV infection
- strategies to prevent transmission of ZIKV infection through assisted reproductive treatment (ART)
- advice on gamete cryopreservation
- optimising investigations for diagnosis of ZIKV in males.
Eligibility
Relevant conditions:
Zika Virus
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov